|
Symbol
|
PMWLTQ | RMAZ2V | Z0972Z | Z0974Z | Z0973Z | ABZHTQ | RMBY0V |
|---|---|---|---|---|---|---|---|
| Nom | Multi Reverse Convertible | Multi Vonti | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | Multi Reverse Convertible | Multi Vonti |
|
Sous-jacent
|
Amgen Inc. / Lonza Group N / Novartis Sandoz Basket / Pfizer Inc. / Roche AG | Altria Group Inc. / Pfizer Inc. / Philip Morris Intl. Inc. | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Coca-Cola / Johnson & Johnson / Pfizer Inc. | Eli Lilly / Pfizer |
|
Emetteur
|
|
|
|
|
|
|
|
|
Échéance
|
09.02.2026 | 09.03.2026 | 04.03.2026 | 04.03.2026 | 04.03.2026 | 21.07.2026 | 30.07.2026 |
| Ratio | - | - | - | - | - | - | - |
|
Prix d'exercise
|
168,34 | 82,22 | 41,9369 | 42,027 | 41,986 | 21,4449 | 705,28 |
| rendement max. p.a. | - | - | - | - | - | - | 10,24% |
| Demande | - | 87,90 | 106,21 | 108,68 | 107,68 | 99,73 | 98,40 |
| Offre | - | - | 106,96 | 109,43 | 108,43 | 100,53 | 99,21 |